维普中文期刊产品整合服务
35篇 您的检索式:作者名="KOUZI"
    题名 作者 年代 出处 被引量
1Insecticidal activity of the diterpenesclareol and its analogs against the fall armyworm Spodoptera frugiperda显示文摘Kouzi SA Dowd PF McChesney JD 1996Natural Product Letter1996,8,3:1
2Chemistry, Biological Activity and Chemotherapeutic Potential of Betulinic Acid for the Prevention and Treatment of Cancer and HIV Infection 显示文摘Robert H Cichewicz Samir A Kouzi 2004Medicinal Research Reviews2004,24,:1
3Studies in natural products chemistry, (Part G); attaur-rahman, Ed 显示文摘CICHEMICZ R KOUZIS A Amsterdam0,26,9:1
4Microbial transformations of the antimelanoma agent betulinic acid 显示文摘Kouzi SA Chatterjee P Pezzuto JM 2000J Mat Prod2000,63,:1
5Chemisiry,biological activity,and chemotherapeutic potential of betulinic acid for the prevevtion and treament of cancer and HIV infection显示文摘CICHEWICA R H KOUZI S A 2004Med Res Rev2004,24,1:1
6Treatment of childhood myopia with atropine eyedrops and bifocal spectacles 显示文摘Chiang MF Kouzis A Pointer RW 2001Binocul Vis Strabismus Q2001,16,3:1
7Psychopathology and mortality in the general population显示文摘Kouzis A Eaton WW Leaf PJ 1995Soc Psychiatry Psychiatr Epidemiol1995,30,4:1
8Mental fatigue caused byprolonged cognitive load associated with sympathetic hyperactivity 显示文摘Kei M Masaaki T Kouzi Y 2011Behavioral and Brain Functions2011,7,:1
9Chemistry,biological activity,and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection显示文摘Cichewicz RH Kouzi SA 2004Med Res Rev2004,24,1:1
10Natural supplements for im- proving insulin sensitivity and glucose uptake in skeletal muscle 显示文摘Kouzi SA Yang S1 Nuzum DS 2015Front Biosci (Elite Ed)2015,7,:1
11A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke显示文摘Alberg AJ Kouzis A Genkinger JM 2007Am J Epidemiol2007,165,6:1
12High imerocular corneal symmetry in average simulated keratometry, central corneal thickness, and !3osterior elevation 显示文摘Myrowitz EH Kouzis AC O' Brien TP 2005Optom Vis Sei2005,82,:1
13Can short-term fasting protect against doxorubicin-induced cardiotoxicity?显示文摘Doxorubicin(Dox) is one of the most effective chemotherapeutic agents used in the treatment of several types of cancer. However the use is limited by cardiotoxicity. Despite extensive investigation into the mechanisms of toxicity and preventative strategies, Dox-induced cardiotoxicity still remains a major cause of morbidity and mortality in cancer survivors. Thus, continued research into preventative strategies is vital. Short-term fasting has proven to be cardioprotective against a variety of insults. Despite the potential, only a few studies have been conducted investigating its ability to prevent Dox-induced cardiotoxicity. However, all show proof-of-principle that short-term fasting is cardioprotective against Dox. Fasting affects a plethora of cellular processes making it difficult to discern the mechanism(s) translating fasting to cardioprotection, but may involve suppression of insulin and insulin-like growth factor-1 signaling with stimulated autophagy. It is likely that additional mechanisms also contribute. Importantly, the literature suggests that fasting may enhance the antitumor activity of Dox. Thus, fasting is a regimen that warrants further investigation as a potential strategy to prevent Dox-induced cardiotoxicity. Future research should aim to determine the optimal regimen of fasting, confirmation that this regimen does not interfere with the antitumor properties of Dox, as well as the underlying mechanisms exerting the cardioprotective effects.Amie J Dirks-Naylor Samir A Kouzi Sendra Yang Ngan TK Tran Joseph D Bero Raean Mabolo Diep T Phan Stephanie D Whitt Heather N Taylor 2014World Journal of Biological Chemistry2014,5,3:1
14Chemistry, biological activity, and chemothera- peutic potential ofbetulinic acid for the prevention and treatment of cancer and HIV infection 显示文摘Cichewicz RH Kouzi SA 2004Med Res Rev2004,24,1:1
15Biotransformation of resveratrol to piceid by Bacillus cereus显示文摘ROBERT H CICHEWICZ SA KOUZI 1998Journal of Natural Products1998,61,:1
16Painful ophthalmoplegia: The role of imaging and steroid response in the acute and subacute setting显示文摘Evangelos Anagnostou Ioanna Kouzi Evangelia Kararizou 2013Journal of the Neurological Sciences . 2013 (1-2)2013,,1:1
17Effects of acute doxorubicin treatment on hepatic proteome lysine acetylation status and the apoptotic environment显示文摘AIM: To determine if doxorubicin(Dox) alters hepatic proteome acetylation status and if acetylation status was associated with an apoptotic environment. METHODS: Doxorubicin(20 mg/kg; Sigma, Saint Louis, MO; n = 8) or NaCl(0.9%; n = 7) was administered as an intraperitoneal injection to male F344 rats, 6-wk of age. Once animals were treated with Dox or saline, all animals were fasted until sacrifice 24 h later. RESULTS: Dox treatment decreased proteome lysine acetylation likely due to a decrease in histone acetyltransferase activity. Proteome deacetylation may likely not be associated with a proapoptotic environment. Dox did not increase caspase-9,-8, or-3 activation nor poly(adenosine diphosphate-ribose) polymerase-1 cleavage. Dox did stimulate caspase-12 activation, however, it likely did not play a role in apoptosis induction. CONCLUSION: Early effects of Dox involve hepatic proteome lysine deacetylation and caspase-12 activa-tion under these experimental conditions.Amie J Dirks-Naylor Samir A Kouzi Joseph D Bero Ngan TK Tran Sendra Yang Raean Mabolo 2014World Journal of Biological Chemistry2014,5,3:1
18Insecticidal activity of the diterpene sclareol and its analogs against the fall armyworm Spodoptera frugiperda 显示文摘Kouzi SA Dowd PF McChesney JD 1996Natural product letter1996,8,3:1
19Treatment of childhood myopia with atropine eyedrops and bifocal spectacles显示文摘Chiang M F Kouzis A Pointer R W and Repka M X 2001Binocul Vis Strabismus Q2001,16,3:1
20Studies in natural products chemistry (Part G);Atta-ur-Rahman,Ed显示文摘CICHEMICZ R H KOUZI S A 2002Amsterdam2002,26,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费